Trademark applications and grants for Revance Therapeutics Inc. Revance Therapeutics Inc has 81 trademark applications. The latest application filed is for "TWICE UPON A TIME"
Patent Application | Date |
---|---|
METHODS OF TREATMENT FOR CERVICAL DYSTONIA 20220096610 - 17/547211 Ruegg; Curtis L. ;   et al. | 2022-03-31 |
Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect 20220062400 - 17/472525 Ruegg; Curtis L. ;   et al. | 2022-03-03 |
Albumin-Free Botulinum Toxin Formulations 20210330766 - 17/322901 Thompson; Stewart A. ;   et al. | 2021-10-28 |
BOTULINUM TOXIN AND THE TREATMENT OF PRIMARY DISORDERS OF MOOD AND AFFECT 20210308236 - 17/234690 Borodic; Gary E. | 2021-10-07 |
BOTULINUM TOXIN AND THE TREATMENT OF PRIMARY DISORDERS OF MOOD AND AFFECT 20210283228 - 17/183934 Borodic; Gary E. | 2021-09-16 |
NCAGE Code | 6PA56 | REVANCE THERAPEUTICS, INC. |
CAGE Code | 6PA56 | REVANCE THERAPEUTICS, INC. |
SEC | 0001388649 | Revance Therapeutics Inc |
SEC | 0001479290 | Revance Therapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.